STOCK TITAN

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

Teladoc Health (NYSE:TDOC) announced an employment inducement award effective March 1, 2026, for Daniel Conroy as Chief Growth Officer, U.S. Group Health.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Teladoc Health (NYSE:TDOC) announced an employment inducement award effective March 1, 2026, for Daniel Conroy as Chief Growth Officer, U.S. Group Health. The grant includes 57,034 restricted stock units and 57,034 performance stock units (target), with up to 114,068 PSU shares earnable.

RSUs vest one-third at the first anniversary, then quarterly over two years; PSUs vest based on three-year financial metrics. The award was approved by the Compensation Committee under the 2023 Employment Inducement Incentive Award Plan per NYSE Rule 303A.08.

Loading...
Loading translation...
Argus Mar 5 session
-0.19% close to close Open Argus
Details

News Market Reaction – TDOC

On Mar 5, the first trading day after this news, TDOC closed 0.19% below the previous close.

Data tracked by StockTitan Argus for the Mar 5 session.

Key Figures

RSU grant size: 57,034 shares PSU target shares: 57,034 shares PSU maximum shares: 114,068 shares +3 more
RSU grant size
57,034 shares
Restricted stock units for new Chief Growth Officer, U.S. Group Health
PSU target shares
57,034 shares
Target performance stock units tied to financial metrics
PSU maximum shares
114,068 shares
Maximum earnable under performance stock unit award
Common stock par value
$0.001 per share
Par value of Teladoc Health common stock
RSU vesting period
3 years
One-third after 1 year, remainder quarterly over 2 years
PSU performance period
3 years
Shares earned over three years based on financial metrics

Historical Context

5 past events · Latest: Feb 25
5 events
  1. Feb 25

    Q4/FY 2025 earnings

    24h Move
    +15.1%

    Reported flat Q4 revenue, FY revenue decline, and improved adjusted EBITDA with outlook.

  2. Feb 18

    Board appointment

    24h Move
    +4.7%

    Added experienced financial executive Michael Smith to board and key committees.

  3. Feb 05

    Earnings date set

    24h Move
    +5.9%

    Announced timing and access details for upcoming Q4 2025 earnings release call.

  4. Jan 12

    Product expansion

    24h Move
    -2.8%

    Launched enhanced 24/7 Care nationwide, broadening virtual urgent care capabilities.

  5. Jan 05

    Investor conference

    24h Move
    +9.9%

    CEO scheduled to present at J.P. Morgan Healthcare Conference with webcast access.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

restricted stock units, performance stock units, par value, employment inducement award
4 terms
restricted stock units financial
"granted an award of restricted stock units covering 57,034 shares of Teladoc Health’s common"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
performance stock units financial
"and an award of performance stock units covering a target of 57,034 shares of Common Stock"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
par value financial
"common stock, par value $0.001 per share (“Common Stock”), and an award of performance"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
employment inducement award financial
"was granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan"
An employment inducement award is a grant of company stock, options, or other equity given to a new hire as a joining bonus to encourage them to work for the company. Like a signing bonus in cash, it ties the employee’s pay to the company’s future value and often vests over time. Investors care because these awards increase outstanding shares and compensation costs, affecting per‑share value and motivating executives to meet performance goals.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.

Effective March 1, 2026, in connection with commencing employment as Chief Growth Officer, U.S. Group Health, Daniel Conroy was granted an award of restricted stock units covering 57,034 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”), and an award of performance stock units covering a target of 57,034 shares of Common Stock (for which up to 114,068 shares may be earned). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The performance stock units provide a target number of shares of Common Stock that would be earned over three years based on various financial metrics. The award was approved by the Compensation Committee of the Board of Directors of Teladoc Health and was granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as an employment inducement award pursuant to New York Stock Exchange Rule 303A.08.

About Teladoc Health

Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.

Media:
Lou Serio
pr@teladochealth.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity did Teladoc Health (TDOC) grant Daniel Conroy on March 1, 2026?

He received 57,034 restricted stock units and a target of 57,034 performance stock units. According to the company, up to 114,068 PSU shares may be earned based on three-year financial metrics.

How do the restricted stock units for TDOC vest for Daniel Conroy?

The RSUs vest one-third on the first anniversary and then quarterly over two years. According to the company, vesting is based on continued service to Teladoc Health.

What performance period applies to the Teladoc Health (TDOC) performance stock units?

The PSUs are measured over a three-year performance period tied to financial metrics. According to the company, payout ranges from a target of 57,034 shares up to 114,068 shares based on results.

Under what plan and rule was the TDOC inducement award granted?

The award was granted under the 2023 Employment Inducement Incentive Award Plan as an inducement award under NYSE Rule 303A.08. According to the company, the Compensation Committee approved the grant.

Will the Teladoc Health (TDOC) inducement award dilute existing shareholders?

The award issues RSUs and PSUs convertible into common stock if vested, which could cause dilution if earned. According to the company, up to 171,102 total shares relate to this grant if all PSUs and RSUs convert.

Keep reading